ArticleAntimicrobial agents and chemotherapy2021

Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study).

A Albasanz-Puig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.